Search research articles
Contact Us
Filters
Showing results (131-140 of 145) with videos related to
Page
of 15
Sort By:
Molecular Oncology
|
November 18, 2025
European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancer
Mangesh A Thorat, Marc Arbyn, David Baldwin, et al.
Diagnosis (Berlin, Germany)
|
August 1, 2024
Bridging the divide: addressing discrepancies between clinical guidelines, policy guidelines, and biomarker utilization
Denis Horgan, Paul Hofman, Reinhard Buttner, et al.
Thorax
|
July 20, 2021
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study
Marzieh Araghi, Miranda Fidler-Benaoudia, Melina Arnold, et al.
Molecular Oncology
|
January 16, 2026
European Code Against Cancer, 5th edition - organised cancer screening programmes
Esther Toes-Zoutendijk, Marc Arbyn, Anssi Auvinen, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
December 26, 2024
Achieving earlier diagnosis of symptomatic lung cancer
Stephen H Bradley, David Baldwin, Bobby Sudhir Kumar Bhartia, et al.
Pilot and Feasibility Studies
|
December 7, 2021
Feasibility and acceptability of transcranial stimulation in obsessive-compulsive symptoms (FEATSOCS): study protocol for a randomised controlled trial of transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder (OCD)
Eduardo Cinosi, David Adam, Ibrahim Aslan, et al.
BMJ Open
|
May 27, 2021
Changes in daily mental health service use and mortality at the commencement and lifting of COVID-19 'lockdown' policy in 10 UK sites: a regression discontinuity in time design
Ioannis Bakolis, Robert Stewart, David Baldwin, et al.
The European Respiratory Journal
|
July 1, 2022
Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial
Philip A J Crosbie, Rhian Gabe, Irene Simmonds, et al.
The European Respiratory Journal
|
April 18, 2024
Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial
Rachael L Murray, Panos Alexandris, David Baldwin, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 16, 2016
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition
Borwin Bandelow, David Baldwin, Marianna Abelli, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 145) with videos related to
Sort By:
Page
of 15
Molecular Oncology
|
November 18, 2025
European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancer
Mangesh A Thorat, Marc Arbyn, David Baldwin, et al.
Diagnosis (Berlin, Germany)
|
August 1, 2024
Bridging the divide: addressing discrepancies between clinical guidelines, policy guidelines, and biomarker utilization
Denis Horgan, Paul Hofman, Reinhard Buttner, et al.
Thorax
|
July 20, 2021
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study
Marzieh Araghi, Miranda Fidler-Benaoudia, Melina Arnold, et al.
Molecular Oncology
|
January 16, 2026
European Code Against Cancer, 5th edition - organised cancer screening programmes
Esther Toes-Zoutendijk, Marc Arbyn, Anssi Auvinen, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
December 26, 2024
Achieving earlier diagnosis of symptomatic lung cancer
Stephen H Bradley, David Baldwin, Bobby Sudhir Kumar Bhartia, et al.
Pilot and Feasibility Studies
|
December 7, 2021
Feasibility and acceptability of transcranial stimulation in obsessive-compulsive symptoms (FEATSOCS): study protocol for a randomised controlled trial of transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder (OCD)
Eduardo Cinosi, David Adam, Ibrahim Aslan, et al.
BMJ Open
|
May 27, 2021
Changes in daily mental health service use and mortality at the commencement and lifting of COVID-19 'lockdown' policy in 10 UK sites: a regression discontinuity in time design
Ioannis Bakolis, Robert Stewart, David Baldwin, et al.
The European Respiratory Journal
|
July 1, 2022
Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial
Philip A J Crosbie, Rhian Gabe, Irene Simmonds, et al.
The European Respiratory Journal
|
April 18, 2024
Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial
Rachael L Murray, Panos Alexandris, David Baldwin, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 16, 2016
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition
Borwin Bandelow, David Baldwin, Marianna Abelli, et al.
Page
of 15